Related Experiment Video
Updated: Jun 2, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Interferon regulatory factors in human lupus pathogenesis.
Rafah Salloum1, Timothy B Niewold
1Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Pritzker School of Medicine, Chicago, IL 60637, USA.
Genetic variants in interferon regulatory factors (IRFs) increase interferon alpha (IFN-α) levels, a key factor in systemic lupus erythematosus (SLE). Understanding these IRF gene variants offers new therapeutic targets for SLE.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease influenced by genetic and environmental factors.
- Interferon alpha (IFN-α) is implicated in SLE pathogenesis, with high serum levels being a heritable risk factor.
- Interferon regulatory factors (IRFs) are transcription factors crucial for immune responses, including IFN-α production.
Purpose of the Study:
- To investigate the role of genetic variants in IRF family genes (IRF5, IRF7, IRF8) in SLE susceptibility.
- To elucidate the mechanism by which IRF variants influence IFN-α production in SLE patients.
- To explore the potential of targeting the Toll-like receptor/IRF/IFN-α pathway for SLE therapeutics.
Main Methods:
- Analysis of genetic variants in IRF5, IRF7, and IRF8 genes in SLE patients.
- Correlation of IRF genotypes with serum IFN-α levels and autoantibody specificities.
- In vivo studies to assess the functional impact of IRF variants on the IFN-α pathway.
Main Results:
- Genetic variants in IRF5 and IRF7 are associated with SLE susceptibility and elevated serum IFN-α.
- The increase in IFN-α due to IRF5/7 variants is contingent upon specific autoantibody profiles.
- Genetic variation in IRF8 also impacts the IFN-α pathway and is linked to SLE.
- SLE-associated IRF polymorphisms appear to be gain-of-function variants.
Conclusions:
- Chronic stimulation of endosomal Toll-like receptors by nucleic acid-containing immune complexes is necessary for IRF risk variants to elevate IFN-α and contribute to SLE.
- IRF family gene variants play a significant role in SLE pathogenesis by modulating the IFN-α pathway.
- Targeting the Toll-like receptor/IRF/IFN-α axis presents a promising therapeutic strategy for SLE.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Transcription Factors
General Transcription Factors
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

